Y S Jagan Mohan Reddy on Tuesday asked the Centre to direct Bharat Biotech and ICMR-NIV to transfer the Covaxin manufacturing technology and provide the viral strain to "whoever is interested and capable of manufacturing the vaccine" so that the production could be ramped up.
In a letter to Prime Minister Narendra Modi, Jagan claimed that the present total manufacturing capacity of Covaxin did not cater to the country's requirement.
"It may take several months to get all vaccinated at this pace. Please explore the possibility of involving all such production firms and enable them with the technology, intellectual property rights to deliver the vaccine as quickly and as affordable as possible," the Chief Minister said.
"Anyone who can manufacture or is interested in manufacturing the vaccine should be encouraged to do so in the larger public interest.Entire manufacturing capacity should be mobilised and put to use in this testing times," Jagan added.
The Chief Minister said "we are not able to vaccinate our population at large" due to short supply of vaccine though the state demonstrated its capacity to inoculate six lakh people per day.
"I look forward to your favourable orders in this matter," Jagan told the Prime Minister.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)